MicroRNAs (miRNAs) with 20–30 nucleotides have recently emerged as the multidimensional regulators of cell fate decisions. Recent improvement in high-throughput sequencing has highlighted the potential role of LIN28/let-7 regulatory network in several developmental events. It was proposed that this pathway might represent a functional signature in cell proliferation, transition between commitment and pluripotency, and regulation of cancer and tumorigenicity. LIN28/let-7 regulatory pathway is one of the excellent examples of the relationship between an miRNA and mRNAs. This review article highlights the potentials of LIN28/let-7 signaling in gene regulatory pathways during pluripotency, reprogramming, and tumorigenicity.
Get full access to this article
View all access options for this article.
References
1.
AmbrosV., and HorvitzH. (1984). Heterochronic mutants of the nematode. Science, 226, 409–416.
BüssingI., SlackF.J., and GroßhansH. (2008). let-7 microRNAs in development, stem cells and cancer. Trends Mol. Med., 14, 400–409.
4.
CarringtonJ.C., and AmbrosV. (2003). Role of microRNAs in plant and animal development. Science, 301, 336–338.
5.
ChienC.-S., WangM.-L., ChuP.-Y., ChangY.-L., LiuW.-H., YuC.-C., LanY.-T., HuangP.-I., LeeY.-Y., Chen, and Y.-W. (2015). Lin28B/Let-7 regulates expression of Oct4 and Sox2 and reprograms oral squamous cell carcinoma cells to a stem-like state. Cancer Res. 75, 2553–2565.
6.
GangarajuV.K., and LinH. (2009). MicroRNAs: Key regulators of stem cells. Nat. Rev. Mol. Cell Biol., 10, 116–125.
7.
HarandiO.F., and AmbrosV.R. (2015). Control of stem cell self-renewal and differentiation by the heterochronic genes and the cellular asymmetry machinery in Caenorhabditis elegans. Proc. Natl. Acad. Sci. U. S. A., 112, E287–E296.
8.
HeoI., JooC., ChoJ., HaM., HanJ., and KimV.N. (2008). Lin28 mediates the terminal uridylation of let-7 precursor MicroRNA. Mol. Cell, 32, 276–284.
9.
HeoI., JooC., KimY.-K., HaM., YoonM.-J., ChoJ., YeomK.-H., HanJ., and KimV.N. (2009). TUT4 in concert with Lin28 suppresses microRNA biogenesis through pre-microRNA uridylation. Cell, 138, 696–708.
10.
HikasaH., SekidoY., and SuzukiA. (2016). Merlin/NF2-Lin28B-let-7 is a tumor-suppressive pathway that is cell-density dependent and hippo independent. Cell Rep. 14, 2950–2961.
11.
JiJ., and WangX.W. (2010). A Yin-Yang balancing act of the lin28/let-7 link in tumorigenesis. J. Hepatol., 53, 974–975.
12.
JiangS., and BaltimoreD. (2016). RNA-binding protein Lin28 in cancer and immunity. Cancer Lett. 375, 108–113.
13.
Jun-HaoE.T., GuptaR.R., and Shyh-ChangN. (2016). Lin28 and let-7 in the metabolic physiology of aging. Trends Endocrinol. Metab., 27, 132–141.
14.
KhoshnamS.E., WinlowW., FarboodY., MoghaddamH.F., and FarzanehM. (2017a). Emerging roles of microRNAs in ischemic stroke: As possible therapeutic agents. J. Stroke, 19, 166.
15.
KhoshnamS.E., WinlowW., and FarzanehM. (2017b). The interplay of MicroRNAs in the inflammatory mechanisms following ischemic stroke. J. Neuropathol. Exp. Neurol. nlx036, 76, 548–561.
16.
KumarL., HaqueR., and NazirA. (2016). Role of microRNA Let-7 in modulating multifactorial aspect of neurodegenerative diseases: An overview. Mol. Neurobiol., 53, 2787–2793.
17.
LeonardoT.R., SchultheiszH.L., LoringJ.F., and LaurentL.C. (2012). The functions of microRNAs in pluripotency and reprogramming. Nat. Cell Biol., 14, 1114–1121.
18.
LiaoT.-T., HsuW.-H., HoC.-H., HwangW.-L., LanH.-Y., LoT., ChangC.-C., TaiS.-K., and YangM.-H. (2016). let-7 modulates chromatin configuration and target gene repression through regulation of the ARID3B complex. Cell Rep. 14, 520–533.
19.
MaX., LiC., SunL., HuangD., LiT., HeX., WuG., YangZ., ZhongX., and SongL. (2014). Lin28/let-7 axis regulates aerobic glycolysis and cancer progression via PDK1. Nat. Commun., 5, 1–13.
20.
MeltonC., JudsonR.L., and BlellochR. (2010). Opposing microRNA families regulate self-renewal in mouse embryonic stem cells. Nature, 463, 621–626.
MossE.G., LeeR.C., and AmbrosV. (1997). The cold shock domain protein LIN-28 controls developmental timing in C. elegans and is regulated by the lin-4 RNA. Cell, 88, 637–646.
23.
NamY., ChenC., GregoryR.I., ChouJ.J., and SlizP. (2011). Molecular basis for interaction of let-7 microRNAs with Lin28. Cell, 147, 1080–1091.
24.
ParisiS., PassaroF., RussoL., MustoA., NavarraA., RomanoS., PetrosinoG., and RussoT. (2017). Lin28 is induced in primed embryonic stem cells and regulates let-7-independent events. FASEB J. 31, 1046–1058.
25.
PasquinelliA.E., ReinhartB.J., SlackF., MartindaleM.Q., KurodaM.I., MallerB., HaywardD.C., BallE.E., DegnanB., and MüllerP. (2000). Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature, 408, 86–89.
26.
PengF., LiT.-T., WangK.-L., XiaoG.-Q., WangJ.-H., ZhaoH.-D., KangZ.-J., FanW.-J., ZhuL.-L., and LiM. (2017). H19/let-7/LIN28 reciprocal negative regulatory circuit promotes breast cancer stem cell maintenance. Cell Death Dis., 8, e2569.
27.
PetrilliA.M., and Fernández-ValleC. (2016). Role of Merlin/NF2 inactivation in tumor biology. Oncogene, 35, 537–548.
28.
PiskounovaE., PolytarchouC., ThorntonJ.E., LaPierreR.J., PothoulakisC., HaganJ.P., IliopoulosD., and GregoryR.I. (2011). Lin28A and Lin28B inhibit let-7 microRNA biogenesis by distinct mechanisms. Cell, 147, 1066–1079.
29.
PowersJ.T., TsanovK.M., PearsonD.S., RoelsF., SpinaC.S., EbrightR., SeligsonM., de SoysaY., CahanP., and TheißenJ. (2016). Multiple mechanisms disrupt the let-7 microRNA family in neuroblastoma. Nature, 535, 246–251.
30.
PungaT., BartoccioniE., LewandowskaM., DamatoV., EvoliA., and PungaA.R. (2016). Disease specific enrichment of circulating let-7 family microRNA in MuSK+ myasthenia gravis. J. Neuroimmunol., 292, 21–26.
31.
RahkonenN., StubbA., MalonzoM., EdelmanS., EmaniM.R., NärväE., LähdesmäkiH., Ruohola-BakerH., LahesmaaR., and LundR. (2016). Mature Let-7 miRNAs fine tune expression of LIN28B in pluripotent human embryonic stem cells. Stem Cell Res. 17, 498–503.
32.
RanX., XiaoC.-H., XiangG.-M., and RanX.-Z. (2017). Regulation of embryonic stem cell self-renewal and differentiation by MicroRNAs. Cell. Reprogram., 19, 150–158.
33.
RehfeldF., RohdeA.M., NguyenD.T.T., and WulczynF.G. (2015). Lin28 and let-7: Ancient milestones on the road from pluripotency to neurogenesis. Cell Tissue Res. 359, 145–160.
34.
ReinhartB.J., SlackF.J., BassonM., PasquinelliA.E., BettingerJ.C., RougvieA.E., HorvitzH.R., and RuvkunG. (2000). The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature, 403, 901–906.
35.
RoushS., and SlackF.J. (2008). The let-7 family of microRNAs. Trends Cell Biol. 18, 505–516.
36.
RybakA., FuchsH., SmirnovaL., BrandtC., PohlE.E., NitschR., and WulczynF.G. (2008). A feedback loop comprising lin-28 and let-7 controls pre-let-7 maturation during neural stem-cell commitment. Nat. Cell Biol., 10, 987–993.
37.
SchmidtM.F. (2014). Drug target miRNAs: Chances and challenges. Trends Biotechnol. 32, 578–585.
38.
ShiX.-B., TepperC.G., and deVere WhiteR.W. (2008). Cancerous miRNAs and their regulation. Cell Cycle, 7, 1529–1538.
39.
Shyh-ChangN., and DaleyG.Q. (2013). Lin28: Primal regulator of growth and metabolism in stem cells. Cell Stem Cell, 12, 395–406.
40.
StefaniG., ChenX., ZhaoH., and SlackF.J. (2015). A novel mechanism of LIN-28 regulation of let-7 microRNA expression revealed by in vivo HITS-CLIP in C. elegans. RNA, 21, 985–996.
41.
TakamizawaJ., KonishiH., YanagisawaK., TomidaS., OsadaH., EndohH., HaranoT., YatabeY., NaginoM., and NimuraY. (2004). Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 64, 3753–3756.
42.
ThorntonJ.E., and GregoryR.I. (2012). How does Lin28 let-7 control development and disease?. Trends Cell Biol. 22, 474–482.
43.
TsialikasJ., and Romer-SeibertJ. (2015). LIN28: Roles and regulation in development and beyond. Development, 142, 2397–2404.
44.
VasudevanS., TongY., and SteitzJ.A. (2007). Switching from repression to activation: MicroRNAs can up-regulate translation. Science, 318, 1931–1934.
45.
VazC., and TanavdeV. (2012). Role of let-7 networks in stem cell maintenance and differentiation. In MicroRNA Let-7. DahiyaN., ed. (Nova Science Publishers, Hauppauge, NY), pp. 43–56.
46.
Virant-KlunI., StåhlbergA., KubistaM., and SkutellaT. (2016). MicroRNAs: From female fertility, germ cells, and stem cells to cancer in humans. Stem Cells Int. 2016, 3984937.
47.
WahidF., ShehzadA., KhanT., and KimY.Y. (2010). MicroRNAs: Synthesis, mechanism, function, and recent clinical trials. Biochim. Biophys. Acta, 1803, 1231–1243.
48.
WangX., CaoL., WangY., WangX., LiuN., and YouY. (2012). Regulation of let-7 and its target oncogenes. Oncol. Lett., 3, 955–960.
49.
YangX., LinX., ZhongX., KaurS., LiN., LiangS., LassusH., WangL., KatsarosD., and MontoneK. (2010). Double-negative feedback loop between reprogramming factor LIN28 and microRNA let-7 regulates aldehyde dehydrogenase 1-positive cancer stem cells. Cancer Res. 70, 9463–9472.
50.
YinJ., ZhaoJ., HuW., YangG., YuH., WangR., WangL., ZhangG., FuW., and DaiL. (2017). Disturbance of the let-7/LIN28 double-negative feedback loop is associated with radio-and chemo-resistance in non-small cell lung cancer. PLoS One, 12, e0172787.
51.
ZhangB., and WangQ. (2015). MicroRNA‐based biotechnology for plant improvement. J. Cell Physiol., 230, 1–15.
